Skip to content
TrialScanner

NCT04354246

COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies

Phase 1CompletedCGENLead

Registry record

Lead sponsor
Compugen Ltd
Conditions
Advanced Cancer; Ovarian Cancer; Lung Cancer; Colon Cancer; Plasma Cell Neoplasm
Primary completion
Apr 1, 2026Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04354246 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04354246: COM902 (A TIGIT Inhibitor)... | TrialScanner